Group One Trading
RCKT icon

Group One Trading’s Rocket Pharmaceuticals RCKT Stock Holding History

Group One Trading’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57,382
Closed -$191K – 8324
2026
Q1 		$205K Buy
57,382
+48,178
+523% +$191K ﹤0.01% 4087
2025
Q4 		$32.3K Sell
9,204
-6,280
-41% -$21.5K ﹤0.01% 5955
2025
Q3 		$50.5K Sell
15,484
-50,014
-76% -$158K ﹤0.01% 5953
2025
Q2 		$160K Buy
65,498
+64,414
+5,942% +$326K ﹤0.01% 4552
2025
Q1 		$7.23K Buy
+1,084
New +$10.7K ﹤0.01% 6453
2024
Q3 		– Sell
-6,331
Closed -$130K – 7244
2024
Q2 		$136K Buy
+6,331
New +$145K ﹤0.01% 3706
2022
Q4 		– Sell
-200
Closed -$3.68K – 7943
2022
Q3 		$3K Buy
+200
New +$3.12K ﹤0.01% 7040
2022
Q2 		– Sell
-88
Closed -$1.05K – 8396
2022
Q1 		$1K Buy
+88
New +$1.52K ﹤0.01% 7864
2020
Q1 		– Sell
-501
Closed -$11K – 5660
2019
Q4 		$11K Buy
+501
New +$8.37K ﹤0.01% 4579
2019
Q2 		– Sell
-1,999
Closed -$35K – 5314
2019
Q1 		$35K Buy
1,999
+1,017
+104% +$16.1K ﹤0.01% 3751
2018
Q4 		$15K Sell
982
-28
-3% -$465 ﹤0.01% 4132
2018
Q3 		$25K Buy
+1,010
New +$21.9K ﹤0.01% 4313
2018
Q2 		– Sell
-55
Closed -$1.04K – 5394
2018
Q1 		$1K Sell
55
-625
-92% -$10.2K ﹤0.01% 4707
2017
Q4 		$7K Sell
680
-3,301
-83% -$32.7K ﹤0.01% 4482
2017
Q3 		$28K Sell
3,981
-2,599
-39% -$11.9K ﹤0.01% 3913
2017
Q2 		$50K Buy
6,580
+5,905
+875% +$44K ﹤0.01% 3511
2017
Q1 		$5K Buy
675
+100
+17% +$672 ﹤0.01% 4287
2016
Q4 		$14K Buy
575
+250
+77% +$7.13K ﹤0.01% 3842
2016
Q3 		$12K Buy
+325
New +$10.2K ﹤0.01% 3991

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Group One Trading's RCKT Position: Q2 2026 in Review

Group One Trading sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 57,382 shares — an estimated $191K sold.

Group One Trading first reported a position in RCKT in Q3 2016 and held it in 19 quarters. The position peaked at $205K in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Group One Trading reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 57,382 Rocket Pharmaceuticals shares in Q2 2026, an estimated $191K.
  • Group One Trading first reported a position in Rocket Pharmaceuticals in Q3 2016 and held it in 19 quarters.
  • Group One Trading's Rocket Pharmaceuticals position peaked at $205K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.